# Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

> **NCT00211744** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 24 (estimated)

## Conditions studied

- Obsessive-compulsive Disorder

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00211744
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2018-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211744, "Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00211744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*